tirzepatide eye and Reduced Glaucoma Risk in Diabetes RACGP - Semaglutide links to

This is not just a statistical drop-off

After several months, your baseline metabolic rate decreases slightly because you now weigh lessmeaning your body requires fewer total calories to maintain movement and basic functions

Avoid injecting into: Areas of broken, irritated, or sunburned skin Sites with bruising, swelling, or active infection Scar tissue or stretch marks , which may impair absorption Moles, warts, or skin lesions The area directly around the navel (within 5 cm) Waistbands or areas subject to friction from clothing Any site showing signs of lipohypertrophy (hardened, lumpy, or thickened skin) Mild injection site reactions such as temporary redness, minor swelling, or slight itching are relatively common with subcutaneous injectables and usually resolve within a few hours to days

Wegovy, a drug approved by the U.S

Understanding GLP-1 Medications and their Benefits GLP-1 receptor agonists are commonly used to treat type 2 diabetes and obesity

alongside ref 47, this trial has set the stage for the ongoing PROMINENT study